HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.
Frías M, Rodríguez-Cano D, Cuenca-López F, Macías J, Gordon A, Manzanares-Martín B, Pineda JA, Camacho Á, Torre-Cisneros J, Peña J, Rivero-Juárez A, Rivero A.
Frías M, et al. Among authors: rivero a, rivero juarez a.
Pharmacogenomics J. 2017 Dec;17(6):479-480. doi: 10.1038/tpj.2016.80. Epub 2016 Oct 25.
Pharmacogenomics J. 2017.
PMID: 27779247
No abstract available.